-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CtwXfu3aBkSqqwlElZj+xzIevftEqy1ldF7XnCz4Ml+ro8UXi63a+BfLUwBUN6Ij OEjuPd1QvQnpoBDvQGAWLA== 0000909012-10-000317.txt : 20100521 0000909012-10-000317.hdr.sgml : 20100521 20100521113726 ACCESSION NUMBER: 0000909012-10-000317 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100331 FILED AS OF DATE: 20100521 DATE AS OF CHANGE: 20100521 EFFECTIVENESS DATE: 20100521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-10438 FILM NUMBER: 10850047 BUSINESS ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-205-5340 MAIL ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR/A 1 t305935.txt PERCEPTIVE ADVISORS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F-HR Form 13F COVER PAGE Report for the Calendar Year of Quarter Ended: March 31, 2010 Check here if Amendment [ X ]; Amendment Number: 1 This Amendment (Check only one.): [X] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Perceptive Advisors LLC Address: 499 Park Ave, 25th Floor New York, NY 10022 Form 13F File Number: 28-10438 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Joseph Edelman Title: Managing Member Phone: (646) 205-5342 Signature, Place, and Date of Signing: /s/ Joseph Edelman New York, NY May 20, 2010 [Signature] [City, State] [Date] Report Type (Check only one.): [ X ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 80 Form 13F Information Table Value Total: $ 439,040 (thousands) List of Other Included Managers: {None}
SHRS OR TITLE OF VALUE PRN SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (X1000) AMOUNT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ------------------------------------------------------------------------------------------------------------------------------------ AMAG PHARMACEUTICALS INC COM 00163U106 34,910 1,000,000 C SOLE 1,000,000 ATS MED INC NOTE 6.000%10/1 002083AB9 1,213 1,250,000 PRN SOLE 1,250,000 AVI BIOPHARMA INC COM 2346104 3,671 3,111,019 SH SOLE 3,111,019 ACHILLION PHARMACEUTICALS IN COM 00448Q201 554 200,000 SH SOLE 200,000 ACORDA THERAPEUTICS INC COM 00484M106 3,420 100,000 SH SOLE 100,000 ALEXION PHARMACEUTICALS INC COM 15351109 2,719 50,000 P SOLE 50,000 ALEXION PHARMACEUTICALS INC COM 15351109 31,320 576,046 SH SOLE 576,046 ALEXZA PHARMACEUTICALS INC COM 15384100 1,181 439,856 SH SOLE 439,856 ALLERGAN INC COM 18490102 6,532 100,000 SH SOLE 100,000 AMGEN INC COM 31162100 9,574 160,000 SH SOLE 160,000 AMYLIN PHARMACEUTICALS INC COM 32346108 4,498 200,000 P SOLE 200,000 ARIAD PHARMACEUTICALS INC COM 04033A100 105 30,800 SH SOLE 30,800 ASTRAZENECA PLC SPONSORED ADR 46353108 13,416 300,000 C SOLE 300,000 ATHENAHEALTH INC COM 04685W103 3,290 90,000 P SOLE 90,000 BIOMIMETIC THERAPEUTICS INC COM 09064X101 3,156 240,000 SH SOLE 240,000 BOSTON SCIENTIFIC CORP COM 101137107 217 30,000 SH SOLE 30,000 BRISTOL MYERS SQUIBB CO COM 110122108 5,340 200,000 C SOLE 200,000 BRISTOL MYERS SQUIBB CO COM 110122108 6,675 250,000 SH SOLE 250,000 CAPITAL SR LIVING CORP COM 140475104 1,087 206,700 SH SOLE 206,700 CELL THERAPEUTICS INC COM NO PAR 150934503 1,070 1,980,000 P SOLE 1,980,000 CELL THERAPEUTICS INC COM NO PAR 150934503 290 536,000 C SOLE 536,000 CELL THERAPEUTICS INC COM NO PAR 150934503 833 1,541,091 SH SOLE 1,541,091 CELGENE CORP COM 151020104 7,049 113,760 SH SOLE 113,760 CELSION CORPORATION COM NEW 15117N305 1,777 411,455 SH SOLE 411,455 CERNER CORP COM 156782104 849 10,000 SH SOLE 10,000 CHINA NUOKANG BIO-PHARM INC SPONSORED ADS 16949B113 2,142 345,500 SH SOLE 345,500 COMBIMATRIX CORPORATION *W EXP 99/99/999 20009T113 0 50,000 SH SOLE 50,000 CONCEPTUS INC COM 206016107 11,377 570,000 SH SOLE 570,000 CRUCELL N V SPONSORED ADR 228769105 2,040 100,000 SH SOLE 100,000 CURIS INC COM 231269101 92 30,000 SH SOLE 30,000 EXACT SCIENCES CORP COM 30063P105 1,960 440,400 SH SOLE 440,400 EXELIXIS INC COM 30161Q104 2,765 455,518 SH SOLE 455,518 EXPRESS SCRIPTS INC COM 302182100 3,053 30,000 SH SOLE 30,000 GILEAD SCIENCES INC COM 375558103 4,547 100,000 P SOLE 100,000 GILEAD SCIENCES INC COM 375558103 11,445 251,709 SH SOLE 251,709 GTX INC DEL COM 40052B108 743 221,800 C SOLE 221,800 GTX INC DEL COM 40052B108 1,759 525,000 P SOLE 525,000 GTX INC DEL COM 40052B108 2,502 746,800 SH SOLE 746,800 HMS HLDGS CORP COM 40425J101 3,111 61,016 SH SOLE 61,016 INHIBITEX INC COM 45719T103 795 526,618 SH SOLE 526,618 INTERMUNE INC COM 45884X103 73,104 1,640,200 SH SOLE 1,640,200 INVERNESS MED INNOVATIONS IN COM 46126P106 1,169 30,000 SH SOLE 30,000 KERYX BIOPHARMACEUTICALS INC COM 492515101 1,274 464,872 SH SOLE 464,872 LIFE TECHNOLOGIES CORP COM 53217V109 5,227 100,000 SH SOLE 100,000 MANNKIND CORP COM 56400P201 344 52,500 SH SOLE 52,500 MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 3,900 155,000 SH SOLE 155,000 MEDIVATION INC COM 58501N101 1,574 150,000 C SOLE 150,000 MERIT MED SYS INC COM 589889104 763 50,000 SH SOLE 50,000 MICROMET INC COM 59509C105 808 100,000 C SOLE 100,000 MILLIPORE CORP COM 601073109 5,280 50,000 SH SOLE 50,000 MINDRAY MEDICAL INTL LTD SPON ADR 602675100 728 20,000 SH SOLE 20,000 MYLAN INC COM 628530107 5,678 250,000 SH SOLE 250,000 ONYX PHARMACEUTICALS INC COM 683399109 6,056 200,000 C SOLE 200,000 OPTIMER PHARMACEUTICALS INC COM 68401H104 6,020 490,200 SH SOLE 490,200 PDL BIOPHARMA INC COM 69329Y104 2,498 402,300 SH SOLE 402,300 PENWEST PHARMACEUTICALS CO COM 709754105 20,512 6,476,446 SH SOLE 4,626,446 PHARMACYCLICS INC COM 716933106 20,955 3,358,106 SH SOLE 3,358,106 PONIARD PHARMACEUTICALS INC COM NEW 732449301 230 200,000 P SOLE 200,000 POZEN INC COM 73941U102 3,161 330,000 SH SOLE 330,000 PROASSURANCE CORP COM 74267C106 2,927 50,000 SH SOLE 50,000 PSIVIDA CORP COM 74440J101 158 40,000 SH SOLE 40,000 RAPTOR PHARMACEUTICAL CORP COM 75382F106 235 125,000 SH SOLE 125,000 RESPONSE GENETICS INC COM 76123U105 568 400,000 SH SOLE 400,000 SPDR S&P 500 ETF TR UNIT SER 1 S&P 78462F103 5,850 50,000 SH SOLE 50,000 SALIX PHARMACEUTICALS INC COM 795435106 13,905 373,300 SH SOLE 373,300 SCICLONE PHARMACEUTICALS INC COM 80862K104 2,042 578,607 SH SOLE 578,607 SEQUENOM INC COM NEW 817337405 2,516 400,000 C SOLE 400,000 SIGA TECHNOLOGIES INC COM 826917106 3 500 SH SOLE 500 SUPERGEN INC COM 868059106 640 200,000 P SOLE 200,000 SUPERGEN INC COM 868059106 78 24,332 SH SOLE 24,332 TARGACEPT INC COM 87611R306 9,854 501,246 SH SOLE 501,246 THERAVANCE INC COM 88338T104 266 20,000 SH SOLE 20,000 3SBIO INC SPONSORED ADR 88575Y105 6,840 552,475 SH SOLE 552,475 TRUBION PHARMACEUTICALS INC COM 89778N102 661 155,520 SH SOLE 155,520 UNITED THERAPEUTICS CORP DEL COM 91307C102 5,078 91,776 SH SOLE 91,776 VERTEX PHARMACEUTICALS INC COM 92532F100 18,392 450,000 C SOLE 450,000 VICAL INC COM 925602104 4,736 1,422,100 SH SOLE 1,422,100 WATSON PHARMACEUTICALS INC COM 942683103 6,266 150,000 SH SOLE 150,000 XENOPORT INC COM 98411C100 3,889 420,000 SH SOLE 420,000 ZIOPHARM ONCOLOGY INC COM 98973P101 1,778 350,000 SH SOLE 350,000 439,040
-----END PRIVACY-ENHANCED MESSAGE-----